LLMpediaThe first transparent, open encyclopedia generated by LLMs

Earl Sutherland Jr.

Generated by GPT-5-mini
Note: This article was automatically generated by a large language model (LLM) from purely parametric knowledge (no retrieval). It may contain inaccuracies or hallucinations. This encyclopedia is part of a research project currently under review.
Article Genealogy
Parent: Roger Guillemin Hop 4
Expansion Funnel Raw 89 → Dedup 0 → NER 0 → Enqueued 0
1. Extracted89
2. After dedup0 (None)
3. After NER0 ()
4. Enqueued0 ()
Earl Sutherland Jr.
NameEarl Sutherland Jr.
Birth dateMarch 19, 1915
Birth placeBurlingame, Kansas, United States
Death dateMarch 9, 1974
Death placeMiami, Florida, United States
NationalityAmerican
FieldsPhysiology, Biochemistry, Pharmacology
WorkplacesVanderbilt University, Washington University in St. Louis, Case Western Reserve University, Vanderbilt University School of Medicine
Alma materWashburn College, University of Washington, Washington University School of Medicine
Known forDiscovery of cyclic AMP as a second messenger, protein kinase A activation
AwardsNobel Prize in Physiology or Medicine (1971), Albert Lasker Award, National Academy of Sciences membership

Earl Sutherland Jr. was an American physician and pharmacologist noted for elucidating intracellular signal transduction mechanisms through the discovery of cyclic adenosine monophosphate (cyclic AMP) as a second messenger. His work transformed understanding of hormone action, linking receptor activation at the cell surface to metabolic responses in the cytoplasm via biochemical intermediates. Sutherland's discoveries influenced research in endocrinology, neuroscience, immunology, and pharmacology and earned him the Nobel Prize in Physiology or Medicine.

Early life and education

Sutherland was born in Burlingame, Kansas, and raised in a milieu shaped by Midwestern communities including Topeka, Kansas and Wichita, Kansas, attending local schools before matriculating at Washburn College. He pursued medicine at Washington University School of Medicine after undergraduate work, training alongside contemporaries from institutions such as Harvard Medical School, Johns Hopkins University School of Medicine, Yale School of Medicine, and Columbia University Vagelos College of Physicians and Surgeons. Influences during his formative years included clinicians and scientists associated with University of Michigan Medical School, University of Chicago Medicine, and Cornell University Hospital for Animals who shaped early exposure to research methodologies and laboratory science.

Scientific career

Sutherland's scientific career spanned clinical training and bench research at prominent centers including Vanderbilt University School of Medicine, Washington University in St. Louis, and Case Western Reserve University School of Medicine. He collaborated with investigators connected to laboratories at Massachusetts General Hospital, Rockefeller University, Scripps Research, Cold Spring Harbor Laboratory, and Dana–Farber Cancer Institute. His research program intersected with work by scientists from National Institutes of Health, Max Planck Institute, Imperial College London, Karolinska Institutet, and Instituto Gulbenkian de Ciência, situating his laboratory within an international network that included figures at University of California, San Francisco, Stanford University School of Medicine, University of Oxford, University of Cambridge, and University of Paris (Sorbonne).

Research on cyclic AMP and discoveries

Sutherland identified cyclic AMP as a mediator of hormone action, demonstrating that hormones such as epinephrine, glucagon, and adrenaline stimulate production of a small intracellular nucleotide which activates downstream enzymes. He showed that cyclic AMP activates protein kinase A (previously described as cyclic AMP-dependent protein kinase), thereby regulating enzymes like glycogen phosphorylase and lipase and modulating metabolic pathways described by investigators at Rockefeller University and Harvard. His experiments linked cell-surface receptors studied in contexts including beta-adrenergic receptor signaling, muscarinic acetylcholine receptor research, and dopamine receptor pharmacology to intracellular nucleotide cascades. Sutherland's work paralleled and informed studies by researchers at Mount Sinai Health System, Brigham and Women's Hospital, University College London, and Monash University, and provided a conceptual framework later expanded by investigations into inositol trisphosphate, diacylglycerol, calcium signaling, and cAMP response element-binding protein.

Academic positions and mentorship

Sutherland held faculty and leadership posts at Vanderbilt University, where he directed research programs linked to departments of Pharmacology and Biochemistry, and at Case Western Reserve University, where he led laboratories that trained postdoctoral fellows and graduate students. His mentorship network included trainees who went on to positions at Johns Hopkins University, University of California, Los Angeles, University of Pennsylvania, Yale University, and University of Michigan. Collaborators and mentees subsequently influenced programs at National Institutes of Health, Howard Hughes Medical Institute, Cold Spring Harbor Laboratory, and international centers such as University of Toronto, University of Sydney, and ETH Zurich.

Awards and honors

Sutherland received the Nobel Prize in Physiology or Medicine in 1971 for discoveries concerning the mechanisms of action of hormones, sharing recognition with other laureates in biomedical sciences associated with Albert Lasker Award for Basic Medical Research traditions. He was elected to the United States National Academy of Sciences and awarded honors from organizations including the American Physiological Society, American Society for Biochemistry and Molecular Biology, Royal Society of London (honorary associations), and international academies such as the Royal Swedish Academy of Sciences. His prize paralleled recognition given to contemporaries like Fritz Lipmann, Konrad Bloch, Andrew Schally, and Roger Guillemin.

Personal life and legacy

Sutherland's personal life connected him to medical and academic communities in Nashville, Tennessee and Cleveland, Ohio, and his legacy endures through institutions and curricula at centers like Vanderbilt University Medical Center, Case Western Reserve University School of Medicine, and departments across United States Department of Health and Human Services-funded research networks. His discovery of cyclic AMP established paradigms that shaped subsequent breakthroughs in pharmaceutical development at companies and research centers such as Pfizer, Merck & Co., GlaxoSmithKline, Novartis, AstraZeneca, Roche, Johnson & Johnson, and spurred basic research in laboratories at NIH, Wellcome Trust, and private foundations. Sutherland's scientific contributions are commemorated in lecture series, endowed chairs, and museum exhibits linked to institutions including Vanderbilt University, Washington University in St. Louis, and Case Western Reserve University.

Category:American physiologists Category:Nobel laureates in Physiology or Medicine Category:1915 births Category:1974 deaths